Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans-Reference-Cited by-同舟云学术

Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans

Published:2017-07-09 Issue:4 Volume:121 Page:272-278
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Kim Hun-Sung¹²,Lee Hyeseon³,Lee Sue Hyun⁴,Jeong Yoo Jin¹,Kim Tong Min¹,Yang So Jung¹,Baik Sun Jung¹,Kim Hyunah⁵,Lee Seung-Hwan²,Cho Jae Hyoung²,Choi In-Young¹,Yoon Kun-Ho¹²,Kim Ju Han⁴

Affiliation:

1. Department of Medical Informatics; College of Medicine; The Catholic University of Korea; Seoul Korea

2. Division of Endocrinology and Metabolism; Department of Internal Medicine; College of Medicine; Seoul St. Mary's Hospital; The Catholic University of Korea; Seoul Korea

3. Department of Industrial and Management Engineering; Pohang University of Science and Technology; Seoul Korea

4. Division of Biomedical Informatics, Systems Biomedical Informatics Research Centre; Seoul National University College of Medicine; Seoul Korea

5. College of Pharmacy; Sookmyung Women's University; Seoul Korea

Funder

Korean Health Technology R&D Project

Ministry of Health and Welfare

National Research Foundation of Korea

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12765/fullpdf

Reference24 articles.

1. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report;National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);Circulation,2002

2. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines;Stone;Circulation,2014

3. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial;Nakamura;Lancet,2006

4. A comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: the pravastatin anti-atherosclerosis trial in the elderly (PATE);Ito;J Atheroscler Thromb,2001

5. Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project;Byington;Circulation,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety and clinical outcome associated with statin use for primary prevention in Korean patients with low-density lipoprotein cholesterol level ≥ 190 mg/dL: A retrospective cohort study;PLOS ONE;2023-06-12

2. Cardiovascular Event Rates in Statin-Treated Korean Patients with Cardiovascular Disease: Estimates from a Real-World Population Using Electronic Medical Record Data;Cardiovascular Drugs and Therapy;2021-10-08

3. Effects of Statin Therapy on the Risk of Intracerebral Hemorrhage in Korean Patients with Hyperlipidemia;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2019-01-29

4. Proceed with Caution When Using Real World Data and Real World Evidence;Journal of Korean Medical Science;2019

5. Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE);Clinical Hypertension;2018-12